MIT tech review says Sangamo found BLC11A target crispr patent | SGMO Message Board Posts


Sangamo Therapeutics, Inc.

  SGMO website

SGMO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  177112 of 178390  at  12/7/2023 1:19:40 PM  by

gomasna

The following message was updated on 12/7/2023 1:23:23 PM.

 In response to msg 177109 by  gomasna
view thread

Re: MIT tech review says Sangamo found BLC11A target crispr patent

So based on the information in this article that Boston Children's Hospital patented the BCL11A knockout and CRISPR/Vertex has paid for rights to use it, Sangamo has no rights to exclude, although Sangamo patents should allow for Sangamo's rights to use ZFNs.  


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 0  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board




Financial Market Data provided by
.
Loading...